Carsten Moeller

Title: Carsten Moeller: Innovator in Gynecological Therapeutics

Introduction

Carsten Moeller is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of gynecological therapeutics, particularly through his innovative work on progesterone receptor antagonists and modulators. With a total of 2 patents, his inventions aim to address various gynecological diseases and hormone-dependent conditions.

Latest Patents

Moeller's latest patents include advancements in progesterone receptor antagonists. The first patent relates to progesterone receptor antagonists of general formula I, where R1 can be a hydrogen atom and R2 a hydroxyl group, or R1 and R2 together can form an oxo group. His second patent focuses on nonsteroidal progesterone receptor modulators, detailing a process for their production and their use in pharmaceutical agents. These compounds are designed for the therapy and prophylaxis of gynecological diseases such as endometriosis, leiomyomas of the uterus, dysfunctional bleeding, and dysmenorrhea. Additionally, they are applicable for hormone-dependent tumors, female birth control, and hormone replacement therapy.

Career Highlights

Throughout his career, Carsten Moeller has worked with prominent companies in the pharmaceutical industry, including Bayer Schering Pharma AG and Schering Aktiengesellschaft. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Moeller has collaborated with several professionals in his field, including Ulrike Fuhrmann and Anja Schmidt. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Carsten Moeller's contributions to gynecological therapeutics through his patents demonstrate his commitment to advancing medical science. His work continues to influence the treatment of various gynecological conditions, showcasing the importance of innovation in healthcare.